More “unsubstantiated conclusions” partially sink another origin of life paper

OrigLife_ak17A trio of researchers based in Russia is asking to pull another set of figures and a table from a 2008 paper on modeling ATP formation after an investigation found the fourth researcher – the first author on the paper — “falsified or fabricated” the data they reflect.

The paper, in Origins of Life and Evolution of Biospheres, is the second partial retraction from many of the same authors for the same reason. Both journals also issued erratum notices, which read quite similarly. Here’s the latest note:

Continue reading More “unsubstantiated conclusions” partially sink another origin of life paper

Cell Press investigating possible image manipulation in influential yeast genetics paper

cellCell Press is looking into anonymous allegations that a pair of influential papers on gene activation in yeast may contain more than two dozen instances of image manipulation, according to a spokesperson for the journal.

The accusations first appeared in March on PubPeer, where they triggered a small avalanche of comments, including one asserting “unambiguous and repeated examples of data re-use.”

The concerns raised on PubPeer have even sparked an investigation by an institution in Spain, which found no evidence to support the allegations. But not everyone agrees with that verdict.

Continue reading Cell Press investigating possible image manipulation in influential yeast genetics paper

“[T]hese things can happen in every lab:” Mutant plant paper uprooted after authors correct their own findings

FrontiersThree biologists at Tokyo Gakugei University in Japan have retracted a 2014 Frontiers in Plant Science paper on abnormal root growth in Arabidopsis “in light of new experimental evidence” showing they fingered the wrong mutant gene. The journal editors are hailing the retraction as an “excellent example of self-correction of the scientific record.”

The paper, “Mechanosensitive channel candidate MCA2 is involved in touch-induced root responses in Arabidopsis,” described the abnormally behaving roots of a mca2-null mutant Arabidopsis plant.

A subsequent string of experiments by the same research team—including DNA microarrays, RT-PCR, and a PCR-based genomic deletion analysis—demonstrated that two other mutations that somehow creeped into their experimental populations may have been to blame for the abnormal root behavior.

It’s a notably thorough and informative retraction notice from Frontiers, an open-access publisher with a history of badly handled and controversial retractions and publishing decisions. The notice describes the new experiments and the previous, erroneous results: Continue reading “[T]hese things can happen in every lab:” Mutant plant paper uprooted after authors correct their own findings

Brain paper retracted after university report finds “substantial data misrepresentation”

jneurosci_coverThe Journal of Neuroscience is retracting a 2012 paper on how estrogen produced in the brain shapes the auditory system on the basis of “a report from Northwestern University that describes substantial data misrepresentation” in the paper.

The paper, “Mechanistic Basis and Functional Roles of Long-Term Plasticity in Auditory Neurons Induced by a Brain-Generated Estrogen,” is, according to PubMed, the last one published by its last (and corresponding) author Raphael Pinaud, and first author Liisa Tremere, who were both at Northwestern University at the time. Before his position at Northwestern, Pinaud held positions at the University of Oklahoma and the University of Rochester.

Pinaud and Tremere jointly published a handful of papers on the role of estrogen in the auditory system of the brain starting in 2009, some of which are co-authored by two of the other researchers on the current paper, which has been cited 8 times, according to Thomson Scientific’s Web of Knowledge.

Here’s the retraction notice:

Continue reading Brain paper retracted after university report finds “substantial data misrepresentation”

Harvard biofilm paper in Cell breaks down after challenged findings can’t be repeated

CELL_161_4.inddResearchers at Harvard have retracted a Cell paper on biofilm disassembly after they repeated the experiment—following contradictory results from another team—and the new results “can no longer support” the original conclusions.

The 2012 paper, “A Self-Produced Trigger for Biofilm Disassembly that Targets Exopolysaccharide,” describes a factor called norspermidine, produced by the bacteria Bacillus subtilis, that appeared to break down biofilms. The researchers used it to prevent biofilm formation of B. subtilis, Escherichia coli, and Staphylococcus aureus. The paper was cited 72 times, according to Thomson Scientific’s Web of Knowledge.

Two years after it was published, a team from University of Texas Southwestern Medical Center in Dallas and the University of Dundee in the UK contradicted the findings in another Cell publication, “Norspermidine Is Not a Self-Produced Trigger for Biofilm Disassembly.” This time, the authors concluded that norspermidine is not present in B. subtilis biofilms, and actually promotes, rather than breaks down, biofilms. They wrote: Continue reading Harvard biofilm paper in Cell breaks down after challenged findings can’t be repeated

“[W]e can learn from these bad actors:” Trail of retractions follows former Vanderbilt researcher’s fraud

JPhysiol_ak15Authors have retracted three papers from the Journal of Physiology because they contained “falsified or fabricated data.”

The papers, which address calcium signaling in heart muscle cells, are among the six pegged for retraction after an Office of Research Integrity (ORI) investigation into one of the authors, Igor Dzhura, formerly of Vanderbilt University. The ORI found that Dzhura had committed an enormous amount of fraud, involving dozens of faked images and more.

Dzhura was fired from a job at Novartis in November after the company discovered that his application had included the fraudulent work.

The three retracted Journal of Physiology papers and their citation figures, courtesy of Thomson Scientific’s Web of Knowledge, are: Continue reading “[W]e can learn from these bad actors:” Trail of retractions follows former Vanderbilt researcher’s fraud

Dude, whose gene is that? Genetics paper retracted for lack of permission

pbrPlant Biotechnology Reports is retracting a 2009 paper by a group of researchers in South Korea because the authors submitted the article “without the permission” of the owner of a gene used in the study.

The paper abstract is no longer online, though the Committee on Publication Ethics (COPE) recommends that retraction notices be linked to the retracted article wherever possible. So we can’t even tell you what the paper is about, outside of its title: “T1 transgenic tobacco plants carrying multicopy T-DNAs at the same locus exhibit various expression levels of transgenes.”

Here’s all we’ve got—the retraction notice itself: Continue reading Dude, whose gene is that? Genetics paper retracted for lack of permission

NIH cancer paper retracted for faked data

JCIFollowing an investigation into research misconduct, the Journal of Clinical Investigation has retracted a cancer genetics paper from a laboratory at the National Institutes of Health due to “data falsification and fabrication” of four figures and a table in the paper.

The paper, “FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer,” describes an overexpressed gene in mouse prostate cancers that appears to suppress immune system cells.

The journal retracted the paper following an investigation into author Stephanie K. Watkins, then a postdoctoral fellow at the National Cancer Institute. According to a NIH press release released about the study in March 2011, the work “has led to the submission of a patent application by the NIH on behalf of Hurwitz and Watkins to target FOXO3 as a way to boost immune responses in cancer and to silence excessive immune responses in autoimmune diseases.” We found an NIH record of the patent application, but no record of an approved patent at the United States Patent and Trademark Office under either Hurwitz or Watkins’ names.

The paper has been cited 62 times, according to Thomson Scientific’s Web of Knowledge. Here’s the full notice: Continue reading NIH cancer paper retracted for faked data

Drunk rats paper wasted by “significant statistical errors”, among other issues

MolBiolRep_ak5Authors from Xinxiang Medical University in Weihui, China, are retracting a 2014 paper in Molecular Biology Reports because… well, because lots of things.

The researchers exposed nine rats to acute levels of alcohol then compared them to unexposed mice rats, noting differences in gene expression and molecular pathways.

But no one is toasting these findings anymore. Here are the details behind the retraction, courtesy of the notice:

Continue reading Drunk rats paper wasted by “significant statistical errors”, among other issues

Authors retract leptin paper due to “fabricated data”

CellPress_ak2The authors of a study on the effects of the hormone leptin on the liver have retracted it from Cell Metabolism, almost four months after the Office of Research Integrity (ORI) determined it contained faked data, courtesy of its first author.

However, the authors say that the paper’s conclusions remain valid, and are supported by new experiments and additional research by outside groups.

Here’s more from the retraction notice: Continue reading Authors retract leptin paper due to “fabricated data”